Assembly Biosciences, Inc.
ASMB
$10.03
$0.0250.25%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 112.08M | 94.95M | 109.22M | 112.98M | 130.25M |
| Total Receivables | 400.00K | 400.00K | 400.00K | 43.00K | 343.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.02M | 2.86M | 3.31M | 4.15M | 3.20M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 115.50M | 98.21M | 112.93M | 117.17M | 133.79M |
|
|
|||||
| Total Current Assets | 115.50M | 98.21M | 112.93M | 117.17M | 133.79M |
| Net Property, Plant & Equipment | 3.35M | 1.74M | 2.08M | 2.40M | 2.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 312.00K | 312.00K | 312.00K | 312.00K | 312.00K |
| Total Assets | 119.17M | 100.26M | 115.32M | 119.88M | 136.82M |
|
|
|||||
| Total Accounts Payable | 585.00K | 1.34M | 801.00K | 727.00K | 461.00K |
| Total Accrued Expenses | 9.14M | 6.35M | 6.12M | 4.11M | 6.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 461.00K | 1.33M | 1.30M | 1.15M | 1.22M |
| Total Finance Division Other Current Liabilities | 37.62M | 32.62M | 33.06M | 32.77M | 30.92M |
| Total Other Current Liabilities | 37.62M | 32.62M | 33.06M | 32.77M | 30.92M |
| Total Current Liabilities | 47.80M | 41.64M | 41.27M | 38.75M | 39.23M |
|
|
|||||
| Total Current Liabilities | 47.80M | 41.64M | 41.27M | 38.75M | 39.23M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.63M | 113.00K | 451.00K | 791.00K | 1.12M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 35.38M | 32.51M | 38.92M | 47.74M | 55.38M |
| Total Liabilities | 85.81M | 74.26M | 80.64M | 87.28M | 95.73M |
|
|
|||||
| Common Stock & APIC | 859.50M | 841.75M | 840.95M | 827.67M | 826.93M |
| Retained Earnings | -825.93M | -815.59M | -805.98M | -794.83M | -785.75M |
| Treasury Stock & Other | -211.00K | -156.00K | -293.00K | -239.00K | -81.00K |
| Total Common Equity | 33.36M | 26.00M | 34.68M | 32.60M | 41.10M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.36M | 26.00M | 34.68M | 32.60M | 41.10M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.36M | 26.00M | 34.68M | 32.60M | 41.10M |
|
|
|||||